List of works - Lindsay G S Bengtson

A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants

scientific article published in December 2018

A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants

scientific article published in PLoS ONE

Association of household income and adverse outcomes in patients with atrial fibrillation

scientific article published on 06 March 2020

Comparable ascertainment of newly-diagnosed atrial fibrillation using active cohort follow-up versus surveillance of centers for medicare and medicaid services in the atherosclerosis risk in communities study.

scientific article published on 11 April 2014

Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation.

scientific article published on 23 November 2016

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.

scientific article published on 6 September 2017

Impact of atrial fibrillation on healthcare utilization in the community: the Atherosclerosis Risk in Communities study.

scientific article published on 30 October 2014

Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation

scientific article published in August 2018

Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin

scientific article published on 3 July 2014

Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC Study (Atherosclerosis Risk in Communities).

scientific article published on 10 November 2016

Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study

scientific article

Oral anticoagulants and liver injury: the threat of uncontrolled confounding

scientific article published in January 2018

Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation

scientific article published on 5 January 2017

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.

scientific article

Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer

scientific article published on 01 October 2018

Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation.

scientific article published on 17 March 2017

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy.

scientific article

Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation

scientific article published on 04 September 2019

Temporal trends in the occurrence and outcomes of atrial fibrillation in patients with acute myocardial infarction (from the Atherosclerosis Risk in Communities Surveillance Study).

scientific article published on 18 June 2014

Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).

scientific article published on August 2016

List of works by Lindsay G S Bengtson

A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants

A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants

Association of household income and adverse outcomes in patients with atrial fibrillation

Comparable ascertainment of newly-diagnosed atrial fibrillation using active cohort follow-up versus surveillance of centers for medicare and medicaid services in the atherosclerosis risk in communities study.

Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation.

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.

Impact of atrial fibrillation on healthcare utilization in the community: the Atherosclerosis Risk in Communities study.

Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation

Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin

Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC Study (Atherosclerosis Risk in Communities).

Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study

Oral anticoagulants and liver injury: the threat of uncontrolled confounding

Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.

Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer

Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation.

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy.

Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation

Temporal trends in the occurrence and outcomes of atrial fibrillation in patients with acute myocardial infarction (from the Atherosclerosis Risk in Communities Surveillance Study).

Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).